---
title: "Liver and Biliary Imaging"
sidebar_label: "Chapter 5: Liver and Biliary System"
---

# Liver and Biliary Imaging

The liver and biliary system are among the most commonly imaged structures in abdominal radiology. A thorough understanding of normal anatomy, imaging techniques, and pathological appearances is essential for accurate diagnosis.

## Liver Anatomy on Imaging

### Segmental Anatomy (Couinaud Classification)
- **Segment I**: Caudate lobe — posterior, between IVC and portal vein
- **Segments II-IV**: Left lobe (II-III lateral, IV medial)
- **Segments V-VIII**: Right lobe (V-VI anterior inferior/posterior inferior, VII-VIII posterior superior/anterior superior)
- **Clinical relevance**: Surgical resection planning based on segments

### Hepatic Vasculature
- **Portal vein**: Supplies 75% of hepatic blood flow
- **Hepatic artery**: Supplies 25% of blood flow but 50% of oxygen
- **Hepatic veins**: Three main veins draining into IVC
- **Portal triad**: Portal vein branch + hepatic artery + bile duct

## Ultrasound of the Liver

### Normal Appearances
- **Echogenicity**: Isoechoic or mildly hyperechoic to renal cortex
- **Surface**: Smooth, well-defined
- **Vasculature**: Portal veins visible as echogenic walls; hepatic veins anechoic

### Hepatomegaly Assessment
- **Craniocaudal span**: >15 cm in mid-clavicular line
- **Causes**: Fatty liver, hepatitis, congestive heart failure, infiltrative diseases

### Fatty Liver (Hepatic Steatosis)
- **Increased echogenicity**: Liver brighter than kidney
- **Reduced penetration**: Posterior acoustic attenuation
- **Grades**: Mild, moderate, severe based on echogenicity difference

## CT of the Liver

### Enhancement Phases
| Phase | Timing | Best For |
|-------|--------|---------|
| Non-contrast | — | Calcifications, hemorrhage, baseline density |
| Arterial | 20-30s | Hypervascular tumors (HCC, hemangioma flash fill) |
| Portal venous | 60-70s | Metastases, liver parenchyma |
| Delayed | 3-5 min | Cholangiocarcinoma (delayed enhancement), washout |

### Normal Liver CT Density
- **Non-contrast**: 55-65 HU (denser than spleen)
- **Fatty liver**: &lt;40 HU, less dense than spleen
- **Cirrhosis**: Nodular surface, lobar volume changes

## Common Liver Lesions

### Benign Lesions

#### Hepatic Cyst
- **US**: Anechoic, thin wall, posterior acoustic enhancement
- **CT**: Follows water density (0-10 HU), no enhancement
- **Management**: No treatment needed

#### Hemangioma
- **Most common benign hepatic tumor**
- **US**: Echogenic lesion, may show posterior enhancement
- **CT**: Peripheral nodular enhancement in arterial phase, progressive fill-in on delayed
- **MRI**: Very bright on T2, "light bulb" sign

#### Focal Nodular Hyperplasia (FNH)
- **Pathology**: Hyperplastic hepatocytes around central vascular scar
- **CT**: Strongly enhancing in arterial phase, central stellate scar
- **MRI**: Iso/hypointense T1, iso/slightly hyperintense T2, central scar bright on delayed
- **Nuclear medicine**: Sulfur colloid uptake (Kupffer cells)

#### Hepatic Adenoma
- **Association**: Oral contraceptive use, glycogen storage disease
- **Risk**: Hemorrhage, malignant transformation
- **CT**: Arterial enhancement, may contain fat or blood products

### Malignant Lesions

#### Hepatocellular Carcinoma (HCC)
- **Background**: Usually cirrhosis (hepatitis B/C, alcoholic liver disease)
- **Hallmark CT pattern**: Arterial phase enhancement + portal venous washout
- **LIRADS**: Standardized reporting system (LI-RADS 1-5)
- **AFP**: Elevated in majority
- **Complications**: Portal vein tumor thrombus, satellite nodules

#### Cholangiocarcinoma
- **Intrahepatic type**: Mass-forming, peripheral duct dilation
- **CT**: Delayed progressive enhancement (fibrous stroma)
- **Perihilar type (Klatskin tumor)**: Biliary obstruction at hepatic hilum
- **Distal type**: Obstructs common bile duct

#### Liver Metastases
- **Most common hepatic malignancy** in Western countries
- **Hypovascular metastases**: Colorectal, gastric — best seen portal venous phase
- **Hypervascular metastases**: Neuroendocrine, renal cell, thyroid — arterial phase
- **Number and distribution**: Important for staging and resectability

## Biliary System Imaging

### Normal Biliary Anatomy
- **Intrahepatic ducts**: &lt;2 mm diameter
- **Common hepatic duct**: &lt;6 mm
- **Common bile duct (CBD)**: &lt;8 mm (up to 10 mm post-cholecystectomy, or with age)
- **Cystic duct**: Joins CHD to form CBD

### Gallbladder Assessment

#### Cholelithiasis (Gallstones)
- **Ultrasound**: Echogenic foci with posterior acoustic shadowing — gold standard
- **CT**: Only 10-15% of gallstones are radio-opaque
- **Types**: Cholesterol (lucent), pigment (dense or variable), mixed

#### Acute Cholecystitis
- **US findings**:
  - Gallstones (90% of cases)
  - Gallbladder wall thickening >3 mm
  - Pericholecystic fluid
  - Sonographic Murphy's sign (tender under probe)
  - Hyperaemia on Doppler
- **CT findings**: Wall thickening, pericholecystic stranding, subserosal edema

#### Acalculous Cholecystitis
- **Setting**: ICU patients, trauma, burns, prolonged fasting
- **Diagnosis**: Wall thickening, intraluminal sludge without stones

#### Gangrenous Cholecystitis
- **CT**: Asymmetric wall thickening, gas in wall or lumen, defects in wall enhancement
- **Complication**: Perforation, pericholecystic abscess

### Biliary Obstruction

#### Causes by Level
- **Intrahepatic**: Cholangiocarcinoma, metastases
- **Hilum**: Klatskin tumor, lymphadenopathy
- **CBD**: Choledocholithiasis, pancreatic head mass, stricture

#### Imaging Features
- **Biliary dilatation**: CBD >8 mm, intrahepatic ducts visible
- **"Double duct" sign**: Dilated CBD and pancreatic duct — suggests pancreatic head carcinoma
- **MRCP**: Gold standard non-invasive biliary imaging

### Primary Sclerosing Cholangitis (PSC)
- **Association**: IBD (ulcerative colitis in 80%)
- **MRCP findings**: Multifocal strictures and dilatations — "beaded" appearance
- **Complication**: Cholangiocarcinoma

### Choledochal Cysts
- **Todani Classification**: Type I (most common — fusiform CBD dilation) to Type V (Caroli disease)
- **Risk**: Cholangiocarcinoma, cholelithiasis, cholangitis

## MRCP (MR Cholangiopancreatography)

### Technique
- Heavily T2-weighted sequences
- Stationary fluid appears bright (bile, pancreatic juice)
- No radiation, no contrast required
- Excellent bile duct visualization

### Clinical Applications
- **Choledocholithiasis**: Filling defects in bright bile duct
- **Biliary strictures**: Narrowing, level assessment
- **Pancreatic duct**: Dilatation, strictures (main duct IPMN)

## Nuclear Medicine

### HIDA Scan (Hepatobiliary Iminodiacetic Acid)
- **Agent**: Tc-99m HIDA (or DISIDA)
- **Principle**: Excreted in bile, outlines biliary system
- **Indications**: Acute cholecystitis (non-filling gallbladder), biliary leak, neonatal hepatitis vs. biliary atresia
- **Biliary atresia**: No tracer reaches bowel despite hepatic uptake

Understanding liver and biliary imaging is fundamental to managing common clinical presentations including right upper quadrant pain, jaundice, and suspected malignancy.
